Kennard Kollaus
Family Medicine · Eagle Pass, TXNPI 1528147063
Payments from drug & device makers
Across 160 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$665
- AbbVie$238
- Lilly USA, LLC$233
- Bayer$224
- Merck$143
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,695100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $1,116 |
| AstraZeneca | 22 | $665 |
| AbbVie(2 entities) | 10 | $238 |
| Lilly USA, LLC | 13 | $233 |
| Bayer | 4 | $224 |
| Merck | 7 | $143 |
| Sanofi-aventis U.S. LLC | 4 | $121 |
| Sanofi Pasteur Inc. | 6 | $117 |
| Novartis | 5 | $112 |
| Johnson & Johnson | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Pfizer | 1 | $68 |
| Stryker | 1 | $67 |
| Amgen | 4 | $59 |
| Esperion Therapeutics, Inc. | 1 | $58 |
| Biotronik Inc. | 1 | $55 |
| GSK | 3 | $49 |
| Livanova USA, Inc. | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Exact Sciences | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$3,695 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 242 | $253,150 |
| JanuviaSitagliptin Phosphate | 163 | $233,809 |
| FarxigaDapagliflozin Propanediol | 113 | $148,820 |
| HumiraAdalimumab | 13 | $86,913 |
| JardianceEmpagliflozin | 42 | $72,248 |
| EliquisApixaban | 35 | $41,833 |
| TradjentaLinagliptin | 26 | $37,921 |
| LinzessLinaclotide | 44 | $28,445 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $22,866 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $21,275 |
| VascepaIcosapent Ethyl | 24 | $19,524 |
| XareltoRivaroxaban | 20 | $17,258 |
| EntrestoSacubitril/Valsartan | 18 | $14,403 |
| TrulicityDulaglutide | 13 | $12,780 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $11,989 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,116 | $253,150242 claims |
| MerckJanuvia, Janumet | $143 | $242,048178 claims |
| AstraZenecaFarxiga, Symbicort | $665 | $152,905126 claims |
| AbbVieHumira, Linzess | $238 | $115,35857 claims |
| Boehringer IngelheimJardiance, Tradjenta | $14 | $110,16968 claims |
| PfizerEliquis | $68 | $41,83335 claims |
| Johnson & JohnsonXarelto | $89 | $17,25820 claims |
| NovartisEntresto | $112 | $14,40318 claims |
| Lilly USA, LLCTrulicity | $233 | $12,78013 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $24 | $10,98116 claims |
| Sanofi-aventis U.S. LLCLantus | $121 | $6,26831 claims |
| GSKShingrix | $49 | $3,27615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Eagle Pass
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.